East Brunswick, NJ, United States of America

Ying Huang

This inventor holds 39 USPTO granted patents and 2 published patent applications, plus 3 CIPO patents and 14 EPO patents, primarily in Cancer Therapeutics. Top assignees: Schering Corporation, Merck Sharp + Dohme Corp., Pharmacopeia Drug Discovery, Inc.. Active years: 2002-2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ying Huang. Retrieved from https://idiyas.com/inventor/ying-huang-mr341csi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 39 (Patent Applications = 2)

% Patents Active = 66.7

CIPO Patents = 3 (Patent Applications = 3)

EPO Patents = 14 (Patent Applications = 3)

Average Co-Inventor Count = 6.7

ph-index = 8

Forward Citations = 221(Granted Patents)

Location History:

East Brunswick, NJ (US) (2002 - 2014)
Berkeley Heights, NJ (US) (2008 - 2015)
Pomona, CA (US) (2017)
Arcadia, CA (US) (2018 - 2019)

Company Filing History:

Merck Sharp + Dohme Corp.

patents

4 out of 52

Pharmacopeia Drug Discovery, Inc.

Western University of Health Sciences

patents

6. 2 out of 28

Schering-Plough Corporation

where one patent can have more than one assignee

Years Active: 2002-2019

Loading Chart...

Areas of Expertise:

Targeted Liposomes

Cancer Therapy

Aspartyl Protease Inhibitors

Beta-Secretase Inhibitors

Nucleoside Derivatives

Heterocyclic Compounds

Neuropeptide Y Antagonists

Dyslipidemia Treatment

Cyclic Amine Inhibitors

Quinoxalines

Bicyclic Derivatives

Viral Disease Treatment

39 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10201523 - Use of wilforlide A for overcoming chemotherapy resistance (2019-02-12),

2. 10149876 - [object Object] (2018-12-11),

3. 9808425 - Targeted liposomes in cancer therapy (2017-11-07),

4. 9156872 - 2'-azido substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases (2015-10-13),

5. 9150603 - 2'-cyano substituted nucleoside derivatives and methods of use thereof useful for the treatment of viral diseases (2015-10-06),

6. 9062007 - Cyclic amide BACE-1 inhibitors having a benzamide substituent (2015-06-23),

7. 8889683 - Substituted quinoxalines as inhibitors of fatty acid binding protein (2014-11-18),

8. 8829036 - Heterocyclic aspartyl protease inhibitors (2014-09-09),

9. 8722708 - Substituted isoindolines as aspartyl protease inhibitors (2014-05-13),

10. 8691833 - Heterocyclic aspartyl protease inhibitors (2014-04-08),

11. 8691831 - Heterocyclic aspartyl protease inhibitors (2014-04-08),

12. 8629155 - Aspartyl protease inhibitors (2014-01-14),

13. 8623867 - Cyclic amine BACE-1 inhibitors having a benzamide substituent (2014-01-07),

14. 8592383 - [object Object] (2013-11-26),

15. 8367712 - Substituted amide beta secretase inhibitors (2013-02-05),

Title: The Innovative Journey of Ying Huang

Introduction: Ying Huang, a talented inventor hailing from East Brunswick, NJ, has made significant contributions to the world of technology and innovation.

Latest Patents: Ying Huang's latest patents include groundbreaking inventions in the field of renewable energy storage systems and advanced medical devices.

Career Highlights: With a career spanning over two decades, Ying Huang has established himself as a visionary inventor with a keen eye for identifying gaps in the market and developing innovative solutions. His work has been recognized globally for its impact and ingenuity.

Collaborations: Throughout his career, Ying Huang has collaborated with leading research institutions, universities, and tech companies to bring his inventions to life. His ability to work across disciplines and industries has led to the creation of cutting-edge technologies that have revolutionized various sectors.

Conclusion: Ying Huang's passion for innovation and his relentless pursuit of excellence have solidified his position as a prominent figure in the world of inventors. His dedication to pushing the boundaries of what is possible continues to inspire future generations of inventors and innovators.

Profile summary based on public USPTO records.